Avaliamos a eficácia e segurança dos agonistas α‐2 adrenérgicos na redução da mortalidade e das complicações cardíacas em adultos submetidos a cirurgias cardíacas e cirurgias não cardíacas. https://t.co/DOJnieBHa4 https://t.co/7FgRc7Obgm
RT @MortenHylander: Increased risk of harm with use of alpha-2 adrenergic agonists in cardiac and non-cardiac surgery (moderate quality evi…
RT @MortenHylander: Increased risk of harm with use of alpha-2 adrenergic agonists in cardiac and non-cardiac surgery (moderate quality evi…
RT @MortenHylander: Increased risk of harm with use of alpha-2 adrenergic agonists in cardiac and non-cardiac surgery (moderate quality evi…
#Alpha2 adrenergic agonists for the prevention of #Cardiac complications among adults undergoing #Surgery @CochraneUK #ECM https://t.co/LtFKGstOyD
RT @CochraneUK: 'Alpha-2 adrenergic agonists for the prevention of cardiac complications among adults undergoing surgery'..."alpha-2 adrene…
#Alpha2 adrenergic agonists for the prevention of #Cardiac complications among adults undergoing #Surgery https://t.co/ydfh3Ivzyo @CochraneUK #ECM
Using alpha-2 adrenergic agonists to prevent heart complications after major surgery https://t.co/how1o6A1sR
Alpha-2 adrenergic agonists for the prevention of cardiac complications among adults… https://t.co/OACO1ZKQAk